GALECTIN THERAPEUTICS

Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting

18 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update

14 Nov 2024 08:00:01 By Nasdaq GlobeNewswire

Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting

15 Oct 2024 08:00:01 By Nasdaq GlobeNewswire

Galectin Therapeutics to Participate in the H.C. Wainwright MASH Conference

30 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03 Sep 2024 08:30:00 By Nasdaq GlobeNewswire

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update

13 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer

01 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress

04 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update

15 May 2024 08:00:00 By Nasdaq GlobeNewswire

Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Conference

13 May 2024 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

12 Apr 2024 09:45:05 By NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

11 Apr 2024 15:48:32 By NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

10 Apr 2024 10:53:14 By NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

09 Apr 2024 09:50:38 By NetDania Notify

Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis

09 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

08 Apr 2024 16:13:55 By NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

05 Apr 2024 09:46:14 By NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

04 Apr 2024 12:26:47 By NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

03 Apr 2024 12:18:08 By NetDania Notify

NetDania - New 12 months High: GALECTIN THERAPEUTICS INC. - COMMON STOCK

02 Apr 2024 12:37:00 By NetDania Notify